Evoke Pharma, Inc. (EVOK)
NASDAQ: EVOK · Real-Time Price · USD
4.320
+0.160 (3.85%)
Dec 12, 2024, 4:00 PM EST - Market closed
Evoke Pharma Revenue
Evoke Pharma had revenue of $2.65M in the quarter ending September 30, 2024, with 69.83% growth. This brings the company's revenue in the last twelve months to $8.62M, up 100.35% year-over-year. In the year 2023, Evoke Pharma had annual revenue of $5.18M with 106.51% growth.
Revenue (ttm)
$8.62M
Revenue Growth
+100.35%
P/S Ratio
0.45
Revenue / Employee
$2,154,259
Employees
4
Market Cap
6.42M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Elevai Labs | 2.45M |
Mangoceuticals | 755.00K |
ABVC BioPharma | 509.79K |
Syros Pharmaceuticals | 386.00K |
Organovo Holdings | 103.00K |
Ainos | 40.63K |
EVOK News
- 9 days ago - Evoke Pharma Receives Notices of Allowance for Two Additional US Patent Applications Protecting GIMOTI® - GlobeNewsWire
- 4 weeks ago - InvestCloud to Partner with Evoke Advisors to Transform Their Digital Experience - Business Wire
- 5 weeks ago - Evoke Pharma, Inc. Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 6 weeks ago - Evoke Pharma stock surges over 100%—here's why - Invezz
- 7 weeks ago - Evoke Pharma to Showcase Award-Winning Research at the 2024 American College of Gastroenterology Annual Scientific Meeting - GlobeNewsWire
- 7 weeks ago - Evoke Pharma Announces the Appointment of Ben Smeal to the Board of Directors - GlobeNewsWire
- 2 months ago - Evoke Pharma Announces Proceeds from Existing Warrants and Board Expansion - GlobeNewsWire
- 3 months ago - Evoke Pharma Reaffirms Its Commitment to Patients with Gastroparesis Amid Industry Developments - GlobeNewsWire